Glenmede Trust CO Na Ardelyx, Inc. Transaction History

Glenmede Trust CO Na

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$5.05 - $7.1 $20,755 - $29,181	-4,110 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$5.37 - $8.11 $22,070 - $33,332	4,110 New	4,110 $28,000
Q4 2017 Feb 15, 2018	SELL	$4.85 - $7.8 $19,206 - $30,888	-3,960 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.35 - $5.7 $17,226 - $22,572	3,960	3,960 $0

220

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $769M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.